Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Explore scenarios where incorporating mutual funds into an index-based portfolio can improve diversification and adaptability.
24,945 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A major insider sale at LegalZoom prompts questions for investors. This guide breaks down what the move could mean, h...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
Qualcomm sits at a critical crossroads in the semiconductor world, with strong fundamentals and steady cash flow. Thi...
The company behind Claude just filed for an IPO, stirring questions about AI stocks and long-term growth. This guide ...
The latest pullback in software-as-a-service stocks may feel painful, but it also creates patient-buying opportunitie...
Could Amazon outrun Microsoft to join the $3 trillion market-cap club this summer? This article analyzes the math, ca...
Bitcoin rebounds to $60,000 as softer data calms rate-hike fears. This guide breaks down what moved prices, who’s buy...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...